Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
6
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
6
×
life sciences
6
×
national
national blog main
national top stories
new york blog main
new york top stories
pricing
6
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
bristol-myers squibb
medicare
democrats
donald trump
drug price
drug prices
negotiation
sanofi
senate
bill &
buyout
celgene
What
drug
away
bio
house
lower
pharmaceutical
plan
price
prices
roundup
advanced
airport
alnylam’s
american
anathema
annual
answer
apocalypse
approval
awaited
based
beds
best
bff
bringing
celgene
ceos
conference
continue
crash
days
dc
deals
debate
democrat
democratic
dems
details
devoted
discontent
Language
unset
Current search:
pricing
×
biotech
×
" indiana top stories "
×
" life sciences "
×
@xconomy.com
4 years ago
Pelosi, Dems Unveil Price Plan: Are 25 Drugs Enough for Negotiation?
@xconomy.com
4 years ago
After First Look at House Drug Plan, Stocks Rise Slightly
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com
5 years ago
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More